|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||
Part 2: Regional Perspectives in PD |
Los Angeles Biomedical Research Institute, Harbor-UCLA Medical Center, Torrance, and David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, California, U.S.A.
Correspondence to: R. Mehrotra, 1124 W. Carson Street, Torrance, California
90502
U.S.A.
rmehrotra{at}labiomed.org
The proportion of incident U.S. patients with end-stage renal disease
starting chronic peritoneal dialysis (CPD) has historically been low. The low
take-on for CPD in the United States is likely multifactorial, but limited
physician training and inadequate pre-dialysis patient education appear to be
particularly important. Furthermore, two key changes have occurred in the
United States: a steep decline in CPD take-on and a progressive increase in
the use of automated peritoneal dialysis (APD). The decline in CPD take-on has
affected virtually every subgroup examined and has occurred, paradoxically,
when the CPD outcomes in the country have improved. Understanding the reasons
for historically low CPD take-on and recent steep declines in utilization may
allow for plans to reverse these trends to be developed.
KEY WORDS: KEY WORDS:; End-stage renal disease; chronic kidney disease; hemodialysis; initiation of dialysis.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |